Picture of EchoIQ logo

EIQ EchoIQ Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Momentum

Relative Strength (%)
1m-25.62%
3m-20.65%
6m-45.39%
1yr-28.03%
Volume Change (%)
10d/3m-9.45%
Price vs... (%)
52w High-48.65%
50d MA-9.97%
200d MA-24.2%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)36.41
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value5.39
Price to Tang. Book6.78
Price to Free Cashflown/a
Price to Sales1,208.81
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-59.17%
Return on Equity-89.84%
Operating Margin-13277.15%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202630th Jun 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of EchoIQ EPS forecast chart

Profile Summary

EchoIQ Limited is an Australia-based artificial intelligence (AI) and medical technology company. The Company uses AI-driven technology and software to improve decision-making in cardiology. The principal activity of the Company is the development of AI software that aids in predicting Aortic Stenosis heart condition. The Company’s EchoSolv platform harnesses AI-driven analysis of echocardiographic data to assist clinicians in detecting aortic stenosis and other conditions. Its EchoSolv product allows users to assess echocardiographic studies against diagnostic guidelines for structural heart conditions. EchoSolv automatically identifies patients at risk of structural heart disease. EchoSolv improves the standard clinical workflow associated with diagnosis and treatment. The Company’s subsidiaries include HWH Software Pty Ltd, Echo IQ Global Pty Ltd and Echo IQ Incorporated.

Directors

Last Annual
June 30th, 2025
Last Interim
June 30th, 2025
Incorporated
March 31st, 2010
Public Since
December 17th, 2010
No. of Shareholders
4,172
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
645,187,710

EIQ Share Price Performance

Upcoming Events for EIQ

EchoIQ Ltd Annual Shareholders Meeting

Similar to EIQ

Picture of 4DMedical logo

4DMedical

au flag iconAustralian Stock Exchange - SEATS

Picture of Adherium logo

Adherium

au flag iconAustralian Stock Exchange - SEATS

Picture of Ansell logo

Ansell

au flag iconAustralian Stock Exchange - SEATS

Picture of Aroa Biosurgery logo

Aroa Biosurgery

au flag iconAustralian Stock Exchange - SEATS

Picture of Atomo Diagnostics logo

Atomo Diagnostics

au flag iconAustralian Stock Exchange - SEATS

FAQ